Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2009
Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage formEkarat Jantratid, Vincenzo De Maio, Emanuela Ronda, et al.
The Journal of Pharmacy and Pharmacology|September 25, 2014
Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case exampleOrestis Petrakis, Maria Vertzoni, Alexandros Angelou, et al.
Pharmaceutical Research|June 16, 2011
Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adultsDimitrios Psachoulias, Maria Vertzoni, Konstantinos Goumas, et al.
International Journal of Pharmaceutics|November 6, 2016
In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGITAlexandros Kourentas, Maria Vertzoni, Mira Symillides, et al.
Journal of Chromatographic Science|January 30, 2010
A LC-MS-MS method for determination of low doxazosin concentrations in plasma after oral administration to dogsMarijana Erceg, Mario Cindric, Lidija Pozaic Frketic, et al.
Journal of Pharmaceutical Sciences|October 23, 2020
Characteristics of Contents of Lower intestine in the 65-74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release ProductsMaria Vertzoni, Sarah Sulaiman, Konstantinos Goumas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 18, 2016
Effectiveness of supersaturation promoting excipients on albendazole concentrations in upper gastrointestinal lumen of fasted healthy adultsAlexandros Kourentas, Maria Vertzoni, Mira Symillides, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 4, 2025
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguatPaul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 12, 2025
Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 1: in vitro modeling of VericiguatPaul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
Pageof 12